ALLMedicine™ Allergy Immunotherapy Center

Jan 6th, 2022 - Pollen from grasses and trees can trigger allergic rhinitis (AR), where the symptoms and associated consequences can negatively affect quality of life (QoL). The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) is frequently used in clinic...

Jan 2nd, 2022 - Real-world evidence: Methods for assessing long term health and effectiveness of allergy immunotherapy.|2022|Fritzsching B,Contoli M,Porsbjerg C,Buchs S,Larsen JR,|

Sep 28th, 2021 - Allergy immunotherapy from the patient's perspective.|2021|Ballakur SS,An A,Toure M,Reisacher WR,|

Sep 8th, 2021 - The aim of this study was to investigate the time use and both direct and indirect costs associated with subcutaneous immunotherapy (SCIT) for adults with allergic rhinitis (AR) and caregivers of children with AR in the US. We conducted a survey t...

Sep 4th, 2021 - European and US allergists generally do not agree on the approach to subcutaneous allergy immunotherapy in patients with multiple allergies. The North American approach is to treat with a mixture that contains all the allergen extracts to which th...

May 28th, 2019 - In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who are at high risk for developing persisting asthma. These risk...

Mar 3rd, 2017 - This study assessed the safety profile of short ragweed (Ambrosia artemisiifolia) in participants with ragweed-induced rhinoconjunctivitis with or without asthma. The primary objective was to compare treatment-emergent adverse events (AEs) for par...

Jan 22nd, 2014 - The primary aim of this trial is to evaluate the dose-response relationship for the ALK tree AIT administered once daily in order to define a dose-range that would be suitable for at-home administration.

Aug 27th, 2013 - The process of immunization as a treatment for allergic disease brings about changes that are not all well understood and the understanding about them is developing constantly. In our study we plan to check a large number of immunological paramete...

Nov 30th, 2021 - A resolution is needed in the ongoing controversy between US and European allergists over the best approach to subcutaneous allergy immunotherapy (SCIT), "since it is likely that one or the other group of patients is receiving sub-optimal treatmen...

Jul 7th, 2021 - This is part 1 of a three-part series. Part 2 is here. Part 3 is here. For the 32 million people in the United States with food allergies, those who seek relief beyond constant vigilance and EpiPens face a confusing treatment landscape. In January...

Nov 15th, 2020 - Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it will be widely adopted has yet to be determined. A few dozen allergists aro...

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...